• EZ Cap™ Mouse IL-12 mRNA: Research Guide

  2026-08-22

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) is an IVT Mouse Interleukin-12 mRNA reagent designed for controlled cytokine expression studies. Its m1Ψ nucleoside, Cap 1 structure, and poly(A) tail support translation-focused immunotherapy research, while delivery performance remains formulation- and model-dependent.

• JNJ-10198409 PDGF Receptor Inhibition Workflows

  2026-08-21

  JNJ-10198409 is a nanomolar platelet-derived growth factor receptor inhibitor for dissecting PDGF-BB-driven proliferation, migration, angiogenesis, and stromal remodeling. This practical guide connects concentration planning, phospho-signaling assays, and functional disease models with troubleshooting strategies for reproducible cancer and fibrotic disorder research.

• ERAD Hijacking for Transmembrane Protein Degradation

  2026-08-21

  The reference study introduces ERAD-engaging chimeras (ERADECs), a small-molecule platform that redirects endoplasmic-reticulum-associated degradation toward transmembrane proteins. Desonide-based PD-L1 degraders demonstrated pathway-dependent activity and stronger in vivo tumor suppression than a clinically used PD-L1 antibody, providing a mechanistic framework for expanding targeted protein degradation beyond conventional cytosolic and lysosomal routes.

• Psora 4: Rethinking Kv1.3 Blockade

  2026-08-20

  Psora 4 is more than a selective Kv1.3 blocker: it is a tool for interrogating how channel state, auxiliary-subunit composition, and T cell phenotype shape immunomodulatory outcomes. This article translates recent KCNE4 findings into practical guidance for mechanism-driven research and preclinical study design.

• Ribonuclease R for circRNA Validation in Pulpitis

  2026-08-20

  Learn how Ribonuclease R (20 U/μL) can enrich circular RNA for mechanistic studies of inflammation and DNA damage without treating RNase resistance as proof of circularity. This workflow translates findings from the circ_0042103/TAF15/NER axis into practical RNA preparation, validation, and troubleshooting choices.

• EPI-001: Reading AR NTD Inhibition Across Models

  2026-08-19

  EPI-001 is an androgen receptor N-terminal domain inhibitor that enables researchers to distinguish ligand-independent AR signaling from downstream phenotypic effects. This article translates prostate and triple-negative breast cancer findings into a rigorous, orthogonal assay strategy while clarifying model limitations.

• Remdesivir (GS-5734): Assay Reliability Guide

  2026-08-19

  This scenario-based guide explains how Remdesivir (GS-5734), SKU B8398, can support controlled antiviral, cell viability, proliferation, and cytotoxicity workflows. It connects formulation, benchmark EC50 values, assay controls, interpretation, and practical product-selection decisions to help researchers build more defensible experiments.

• Disodium Bicinchoninate in Translational Cell Assays

  2026-08-18

  A translational framework for using Disodium bicinchoninate as an aqueous small-molecule reagent in mechanistic cell assays, with lessons from an inflammatory granulosa-cell nanoparticle study and practical guidance for reproducible validation.

• L. plantarum P101 and AMPK in Alcoholic Steatosis

  2026-08-18

  The reference study shows that Lactiplantibacillus plantarum P101 reduced alcohol-induced hepatic lipid accumulation in mice, with pharmacological inhibition supporting a functional requirement for AMPK activation. Its integration of liver phenotyping, gut microbiota profiling, and serum metabolomics also identifies candidate microbial and metabolic correlates that may connect probiotic intervention with the gut–liver axis.

• Indomethacin: Mechanism and Research Workflow

  2026-08-17

  Indomethacin is a nonsteroidal anti-inflammatory drug with preferential COX-1 inhibition, additional PPAR activity, and reported effects on cholesterol-rich membrane domains. This article separates established pharmacology from emerging uses in inflammation research, lipid metabolism study, and membrane signaling modulation.

• PD 173074: FGFR1 and VEGFR2 Inhibition

  2026-08-16

  PD 173074 is an ATP-competitive FGFR1 kinase inhibitor with additional activity against VEGFR2. Structural, biochemical, and animal-model evidence supports its use for FGFR signaling pathway inhibition, angiogenesis inhibition, and cancer research, while product-specific formulation and dosing data require model-dependent validation.

• OM-MSCs Protect the Golgi After Cerebral IRI

  2026-08-15

  This study identifies a PEDF-dependent PI3K/Akt/mTOR mechanism through which olfactory mucosa mesenchymal stem cells reduce Golgi apparatus stress after cerebral ischemia/reperfusion injury. Its combined cell, animal, imaging, and pathway-perturbation design links GOLPH3, oxidative stress, calcium dysregulation, and autophagy to a potentially modifiable neurorestorative process.

• Nystatin (Fungicidin) in Candida Assays

  2026-08-15

  Nystatin (Fungicidin) gives researchers a practical ergosterol-directed tool for Candida growth, biofilm, adhesion, and combination studies. This guide translates recent synergy findings into reproducible workflows, formulation controls, and troubleshooting decisions while keeping animal and clinical interpretations appropriately bounded.

• KPT-330: An Assay Strategy for XPO1 Biology

  2026-08-14

  KPT-330 (Selinexor) is more than a nuclear export inhibitor: it is a mechanistic probe for connecting XPO1 activity with tumor-cell vulnerability. This article translates TNBC combination evidence into practical assay decisions, controls, and interpretation frameworks for cancer research.

• Baicalin Reopens Visual Plasticity in Adult Amblyopia

  2026-08-14

  A 2026 NeuroImage study reports that baicalin reactivates ocular dominance plasticity and restores visual acuity in adult amblyopic mice. Using intrinsic signal optical imaging, electrophysiology, dose comparison, and pharmacological blockade, the authors connect functional recovery with reduced inhibitory signaling in the visual cortex.

450 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page